Effects of nitrous oxide on the production of cytokines and chemokines by the airway epithelium during anesthesia with sevoflurane and propofol

Molecular Medicine Reports

Volumn 8, Issue 6, 2013, Pages 1643-1648

  Kumakura, Seiichiro ^a   Yamaguchi, Keisuke ^a   Sugasawa, Yusuke ^a   Murakami, Taisuke ^a   Kikuchi, Toshihiro ^a   Inada, Eiichi ^a   Nagaoka, Isao ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Airway epithelium; Chemokine; Cytokine; Nitrous oxide; Sevoflurane

Indexed keywords

CHEMOKINE; CYTOKINE; FENTANYL; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROUS OXIDE; PROPOFOL; REMIFENTANIL; SEVOFLURANE; VECURONIUM; ETHER DERIVATIVE; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INHALATION ANESTHETIC AGENT; INTERLEUKIN 6;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BRONCHOSCOPE; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOMETRY; DIAGNOSTIC KIT; ENDOTRACHEAL TUBE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; IN VIVO STUDY; INHALATION ANESTHESIA; MAJOR CLINICAL STUDY; MECHANICAL PROBE; MIDDLE AGED; PREOPERATIVE EVALUATION; RANDOMIZATION; RESPIRATORY EPITHELIUM; SEGMENTAL MASTECTOMY; YOUNG ADULT; ANESTHESIA; BIOSYNTHESIS; BODY FLUID; CONTROLLED STUDY; DRUG EFFECTS; METABOLISM; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT MUCOSA;

ADULT; AGED; ANESTHESIA; ANESTHETICS, INHALATION; BODY FLUIDS; CHEMOKINES; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; METHYL ETHERS; MIDDLE AGED; NITROUS OXIDE; PROPOFOL; RESPIRATORY MUCOSA; YOUNG ADULT;

EID: 84893714489     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1745     Document Type: Article

References (47)

1. Weiser TG, Regenbogen SE, Thompson KD, et al: An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372: 139-144, 2008.
2. Fisher DM and Zwass MS: MAC of desflurane in 60% nitrous oxide in infants and children. Anesthesiology 76: 354-356, 1992.
3. Gupta K, Vohra V and Sood J: The role of magnesium as an adjuvant during general anaesthesia. Anaesthesia 61: 1058-1063, 2006.
4. Myles PS, Leslie K, Chan MT, et al: ENIGMA Trial Group. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology 107: 221-231, 2007.
5. Myles PS, Leslie K, Peyton P, et al; ANZCA Trials Group: Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design. Am Heart J 157: 488-494, 2009.
6. Urman RD and Desai SP: History of anesthesia for ambulatory surgery. Curr Opin Anaesthesiol 25: 641-647, 2012.
7. Nunn JF: Clinical aspects of the interaction between nitrous oxide and vitamin B12. Br J Anaesth 59: 3-13, 1987.
8. Myles PS, Leslie K, Silbert B, Paech M and Peyton P: A review of the risks and benefits of nitrous oxide in current anaesthetic practice. Anaesth Intensive Care 32: 165-172, 2004.
9. Akca O, Lenhardt R, Fleischmann E, et al: Nitrous oxide increases the incidence of bowel distension in patients undergoing elective colon resection. Acta Anaesthesiol Scand 48: 894-898, 2004.
10. Kaisti KK, Langsjo JW, Aalto S, et al: Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans. Anesthesiology 99: 603-613, 2003.
11. Marie RM, Le Biez E, Busson P, et al: Nitrous oxide anesthesia-associated myelopathy. Arch Neurol 57: 380-382, 2000.
12. Schilling RF: Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects. JAMA 255: 1605-1606, 1986.
13. Parbrook GD: Leucopenic effects of prolonged nitrous oxide treatment. Br J Anaesth 39: 119-127, 1967.
14. Mazze RI, Wilson AI, Rice SA and Baden JM: Reproduction and fetal development in rats exposed to nitrous oxide. Teratology 30: 259-265, 1984.
15. Badner NH, Beattie WS, Freeman D and Spence JD: Nitrous oxide-induced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg 91: 1073-1079, 2000.
16. Badner NH, Drader K, Freeman D and Spence JD: The use of intraoperative nitrous oxide leads to postoperative increases in plasma homocysteine. Anesth Analg 87: 711-713, 1998.
17. Tramer M, Moore A and McQuay H: Meta-analytic comparison of prophylactic antiemetic efficacy for postoperative nausea and vomiting: Propofol anaesthesia versus omitting nitrous oxide versus total i.v. anaesthesia with propofol. Br J Anaesth 78: 256-259, 1997.
18. Apfel CC, Korttila K, Abdalla M, et al: A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 350: 2441-2451, 2004.
19. Macario A, Weinger M, Carney S and Kim A: Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 89: 652-658, 1999.
20. Greif R, Akca O, Horn EP, Kurz A and Sessler DI: Supplemental perioperative oxygen to reduce the incidence of surgical wound infection. N Engl J Med 342: 161-167, 2000.
21. Belda FJ, Aguilera L, Garcia de la Asunción J, et al: Supplemental perioperative oxygen and the risk of surgical wound infection. JAMA 294: 2035-2042, 2005.
22. Grief R, Laciny S, Rapf B, Hickle RS and Sessler DI: Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology 91: 1246-1252, 1999.
23. Henderson KA, Raj N and Hall JE: The use of nitrous oxide in anaesthetic practice: a questionnaire survey. Anaesthesia 57: 1155-1158, 2002.
24. Schneemilch CE, Hachenberg T, Ansorge S, Ittenson A and Bank U: Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol 22: 616-623, 2005.
25. Moudgil GC, Gordon J and Forrest JB: Comparative effects of volatile anaesthetic agents and nitrous oxide on human leucocyte chemotaxis in vitro. Can Anaesth Soc J 31: 631-637, 1984.
26. Ishizaka A, Watanabe M, Yamashita T, et al: New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 29: 896-898, 2001.
27. Simon RH and Paine R III: Participation of pulmonary alveolar epithelial cells in lung inflammation. J Lab Clin Med 126: 108-118, 1995.
28. Takizawa H: Airway epithelial cells as regulators of airway inflammation. Int J Mol Med 1: 367-378, 1998.
29. De Conno E, Steurer MP, Wittlinger M, et al: Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology 110: 1316-1326, 2009.
30. Vozzelli MA, Mason SN, Whorton MH and Auten RL Jr: Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. Am J Physiol Lung Cell Mol Physiol 286: L488-L493, 2004.
31. Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C and Schimmer RC: Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res 6: 61-66, 2005.
32. Brunda MJ: Interleukin-12. J Leukoc Biol 55: 280-288, 1994.
33. Tanaka K, Ludwig LM, Kersten JR, Pagel PS and Warltier DC: Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 100: 707-721, 2004.
34. Reutershan J, Chang D, Hayes JK and Ley K: Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. Anesthesiology 104: 511-517, 2006.
35. Lee HT, Kim M, Jan M and Emala CW: Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol Renal Physiol 291: 67-78, 2006.
36. Suter D, Spahn DR, Blumenthal S, Reyes L, Booy C, Z'Graggen BR and Beck-Schimmer B: The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells. Anesth Analg 104: 638-645, 2007.
37. Loop T, Scheiermann P, Doviakue D, et al: Sevoflurane inhibits phorbol-myristate-acetate-induced activator protein-1 activation in human T lymphocytes in vitro: potential role of the p38-stress kinase pathway. Anesthesiology 101: 710-721, 2004.
38. Frohlich D, Rothe G, Wittmann S, Schmitz G, Schmid P, Taeger K and Hobbhahn J: Nitrous oxide impairs the neutrophil oxidative response. Anesthesiology 88: 1281-1290, 1998.
39. Hill GE, English JB, Stanley TH, Kawamura R, Loeser EA and Hill HR: Nitrous oxide and neutrophil chemotaxis in man. Br J Anaesth 50: 555-558, 1978.
40. Kripke BJ, Kupferman A and Luu KC: Suppression of chemotaxis to corneal inflammation by nitrous oxide. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 20: 302-310, 1987.
41. Nunn JF and O'Morain C: Nitrous oxide decreases motility of human neutrophils in vitro. Anesthesiology 56: 45-48, 1982.
42. Welch WD: Effect of enflurane, isoflurane, and nitrous oxide on the microbicidal activity of human polymorphonuclear leukocytes. Anesthesiology 61: 188-192, 1984.
43. Welch WD and Zaccari J: Effect of halothane and N2O on the oxidative activity of human neutrophils. Anesthesiology 57: 172-176, 1982.
44. Bardosi L, Bardosi A and Gabius HJ: Changes of expression of endogenous sugar receptors by polymorphonuclear leukocytes after prolonged anaesthesia and surgery. Can J Anaesth 39: 143-150, 1992.
45. Frohlich D, Rothe G, Schmitz G and Taeger K: Nitrous oxide impairs the signaling of neutrophils downstream of receptors. Toxicol Lett 100-101: 121-127, 1998.
46. Lehmberg J, Waldner M, Baethmann A and Uhl E: Inflammatory response to nitrous oxide in the central nervous system. Brain Res 30: 1246: 88-95, 2008.
47. Sugasawa Y, Yamaguchi K, Kumakura S, Murakami T, Suzuki K, Nagaoka I and Inada E: Effects of sevoflurane and propofol on pulmonary inflammatory responses during lung resection. J Anesth 26: 62-69, 2012.